Ondine Biomedical Inc. (LON:OBI – Get Free Report)’s stock price was up 0.6% on Monday. The stock traded as high as C$8.95 and last traded at C$8.85. 254,715 shares traded hands during trading, a decline of 56% from the average daily volume of 579,686 shares. The stock had previously closed at C$8.80.
Ondine Biomedical Stock Performance
The stock’s 50-day moving average price is C$9.84 and its 200-day moving average price is C$11.75. The company has a market capitalization of C$5.72 billion, a P/E ratio of -1.44 and a beta of 0.30. The company has a current ratio of 0.65, a quick ratio of 8.26 and a debt-to-equity ratio of -8.65.
About Ondine Biomedical
Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.
Recommended Stories
- Five stocks we like better than Ondine Biomedical
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
